Human Milk Oligosaccharides (HMO) Market Analysis: Opportunities, Innovations, and Growth Potential Through 2034

The global human milk oligosaccharides market size was valued at USD 255.86 million in 2024. The market is projected to grow from USD 292.09 million in 2025 to USD 1,821.29 million by 2034, exhibiting a CAGR of 22.60% during 2025–2034.

This upward trajectory is largely fueled by The human milk oligosaccharides (HMO) market is growing rapidly, driven by increasing awareness of their benefits in infant nutrition and health. Found in breast milk, HMOs support immunity, gut health, and beneficial bacteria. Rising research and innovations in HMO production are boosting their use in food, beverages, and pharmaceuticals worldwide.

Market Definition

Human Milk Oligosaccharides (HMO) Market: Focuses on the development and commercialization of HMOs for use in infant formula, supplements, and functional foods to support gut and immune health.

Key Report Highlights

· The report highlights the key region that accounts for the highest revenue share in the global Human Milk Oligosaccharides (HMO) market.

· It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.

· The report outlines the dominant segment that holds a major share of the market.

· It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.

· Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

· Market Value in 2024: USD 255.86 million

· Projected Market Size in 2035: USD 1,821.29 million

· Anticipated CAGR 2035: 22.60%

Get access to the full report or request a complimentary sample for in-depth analysis: https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market

Market Growth Drivers

Growing Demand for Infant Nutrition

As more parents seek alternatives to breastfeeding, demand for infant formulas enriched with human milk oligosaccharides (HMO) is rising. HMOs support immunity, gut health, and brain development, making them essential for infants who cannot be breastfed. This trend is especially strong in regions with high working-mother populations, where formula feeding is more common. The push for premium, functional infant nutrition is a major driver of HMO market growth.

Rising Prebiotic and Probiotic Demand

With increasing awareness of gut health and immunity, consumer interest in prebiotics and probiotics is growing. HMOs, acting as prebiotics, help promote beneficial gut bacteria and overall wellness. Their inclusion in functional foods, supplements, and beverages aligns with rising demand for digestive and immune-boosting products. This trend is set to fuel further growth in the HMO market.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include